Crossref
journal-article
Elsevier BV
Journal of Controlled Release (78)
References
38
Referenced
125
10.1016/S0040-4020(01)81313-2
/ Tetrahedron / Application of the vicinal oxymination reaction with asymmetric induction to the hemisynthesis of taxol and analogues by Mangatal (1989)10.1023/A:1005740222307
/ Cancer Metastasis Rev. / Molecular pathology of breast cancer and its application to clinical management by Walker (1997)10.1021/np50067a001
/ J. Nat. Prod. / The chemistry of taxol, a clinically useful anticancer agent by Kingston (1990)10.1016/0163-7258(91)90004-6
/ Pharmacol. Ther. / Effects of antimitotic agents on tubulin-nucleotide interactions by Correia (1991)10.1016/S0140-6736(94)90754-4
/ Lancet / The taxoids: paclitaxel and docetaxel by Gelmon (1994)10.1097/01.cad.0000131685.06390.b7
/ Anticancer Drugs / Non-allergic nature of docetaxel-induced acute hypersensitivity reactions by Ardavanis (2004)10.2165/00003088-200342070-00005
/ Clin. Pharmacokinet. / Pharmacological effects of formulation vehicles: implications for cancer chemotherapy by ten Tije (2003)10.1023/A:1010618632738
/ Invest. New Drugs / Role of formulation vehicles in taxane pharmacology by van Zuylen (2001)10.1073/pnas.0601755103
/ Proc. Natl. Acad. Sci. U.S.A. / Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo by Farokhzad (2006)10.1016/j.jconrel.2005.12.013
/ J. Control. Release / Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel by Kim (2006)10.1016/j.biomaterials.2008.12.013
/ Biomaterials / PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery by Chan (2009)10.1016/j.jconrel.2008.02.003
/ J. Control. Release / Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles by Hwang (2008)10.1016/j.jconrel.2009.01.018
/ J. Control. Release / Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles by Nam (2009)10.1158/1078-0432.CCR-04-0118
/ Clin. Cancer Res. / Fibrinogen-coated droplets of olive oil for delivery of docetaxel to a fibrin(ogen)-rich ascites from of a murine mammary tumor by Einhaus (2004)10.1080/03639040802005057
/ Drug Dev. Ind. Pharm. / Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel by Gao (2008)10.1016/j.jconrel.2004.10.023
/ J. Control. Release / Stable paclitaxel formulations in oily contrast medium by Lee (2005)10.1158/1535-7163.MCT-07-0261
/ Mol. Cancer Ther. / Efficacy and tissue distribution of DHP107, an oral paclitaxel formulation by Hong (2007)10.1016/S0168-3659(03)00271-2
/ J. Control. Release / Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel by Immordino (2003)10.1016/j.jconrel.2008.04.019
/ J. Control. Release / Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes by Qiu (2008)10.1002/cncr.11547
/ Cancer / Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies by Fracasso (2003)10.1002/jps.21599
/ J. Pharm. Sci. / Docetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studies by Esmaeili (2009)10.1002/jps.21245
/ J. Pharm. Sci. / Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel by Liu (2008)10.1016/j.jconrel.2006.10.009
/ J. Control. Release / Complete regression of xenografted human carcinomas by a paclitaxel-carboxymethyl dextran conjugate (AZ10992) by Sugahara (2007)10.1021/bc060240p
/ Bioconjug. Chem. / Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel by Khandare (2006)10.1158/1078-0432.CCR-07-2019
/ Clin. Cancer Res. / A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity by Banzato (2008)10.1200/JCO.1998.16.7.2557
/ J. Clin. Oncol. / Oral chemotherapy: rationale and future directions by DeMario (1998)10.1634/theoncologist.7-6-516
/ Oncologist / Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overview by Kruijtzer (2002)10.1021/jm800767c
/ J. Med. Chem. / Conjugated chitosan as a novel platform for oral delivery of paclitaxel by Lee (2008)10.1002/(SICI)1099-1263(199905/06)19:3<163::AID-JAT561>3.0.CO;2-H
/ J. Appl. Toxicol. / Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release by Arechabala (1999)10.1006/abio.2000.4908
/ Anal. Biochem. / A novel method of preparation of small intestinal brush border membrane vesicles by polyethylene glycol precipitation by Prabhu (2001)10.1016/0005-2736(78)90440-6
/ Biochim. Biophy. Acta. / A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes: their use in investigating some properties of d-glucose and choline transport systems by Kessler (1978)10.1023/B:PHAM.0000012152.86004.aa
/ Pharm. Res. / Preparation and characterization of reconstructed small intestinal brush border membranes for surface plasmon resonance analysis by Cho (2004)10.1023/B:PHAM.0000033011.56536.c3
/ Pharm. Res. / Surface plasmon resonance studies of the direct interaction between a drug/intestinal brush border membrane by Kim (2004)10.1016/0169-2607(96)01730-0
/ Comput. Methods Programs Biomed. / Add-in macros for rapid and versatile calculation of non-compartmental pharmacokinetic parameters on Microsoft Excel spreadsheets by Sato (1996)10.1021/bc049868v
/ Bioconjug. Chem. / Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure by Safavy (2004){'key': '10.1016/j.jconrel.2009.08.014_bib36', 'first-page': '6158', 'article-title': 'Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir', 'volume': '62', 'author': 'Bardelmeijer', 'year': '2002', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir by Bardelmeijer (2002)10.1016/j.biomaterials.2009.02.045
/ Biomaterials / Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel by Feng (2009)10.1016/S0090-4295(99)00451-3
/ Urology / Taxanes: an overview of the pharmacokinetics and pharmacodynamics by Vaishampayan (1999)
Dates
Type | When |
---|---|
Created | 16 years ago (Aug. 27, 2009, 9:58 a.m.) |
Deposited | 6 years, 3 months ago (May 22, 2019, 2:52 a.m.) |
Indexed | 3 days, 9 hours ago (Sept. 4, 2025, 10:01 a.m.) |
Issued | 15 years, 9 months ago (Dec. 1, 2009) |
Published | 15 years, 9 months ago (Dec. 1, 2009) |
Published Print | 15 years, 9 months ago (Dec. 1, 2009) |
@article{Lee_2009, title={In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration}, volume={140}, ISSN={0168-3659}, url={http://dx.doi.org/10.1016/j.jconrel.2009.08.014}, DOI={10.1016/j.jconrel.2009.08.014}, number={2}, journal={Journal of Controlled Release}, publisher={Elsevier BV}, author={Lee, Eunhye and Kim, Hyungjun and Lee, In-Hyun and Jon, Sangyong}, year={2009}, month=dec, pages={79–85} }